Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neuronetics Inc STIM

Healthcare Medical Devices
Neuronetics, Inc. is a commercial-stage medical technology company. The Company is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength... see more

Recent & Breaking News (NDAQ:STIM)

Neuronetics Reports Second Quarter 2020 Financial and Operating Results

GlobeNewswire August 4, 2020

Neuronetics to Report Second Quarter 2020 Financial and Operating Results and Host Conference Call

GlobeNewswire July 21, 2020

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire July 17, 2020

Neuronetics Announces the Appointment of Keith J. Sullivan as President and Chief Executive Officer

GlobeNewswire July 14, 2020

Neuronetics Announces Appointment of Bruce J. Shook to its Board of Directors

GlobeNewswire June 26, 2020

Neuronetics to Present at the William Blair 40th Annual Growth Stock Conference

GlobeNewswire June 4, 2020

Neuronetics, Inc. Announces Virtual 2020 Annual Meeting of Stockholders

GlobeNewswire May 12, 2020

Neuronetics Recognizes Critical Health Professionals During Mental Health Awareness Month

GlobeNewswire May 7, 2020

Neuronetics Reports First Quarter 2020 Financial and Operating Results

GlobeNewswire May 5, 2020

Neuronetics to Report First Quarter 2020 Financial and Operating Results and Host Conference Call

GlobeNewswire April 21, 2020

Neuronetics, Inc. Adopts Limited Duration Shareholder Rights Plan

GlobeNewswire April 8, 2020

Neuronetics, Inc. Announces Preliminary First Quarter 2020 Revenue, Corporate Restructuring, and Provides Business Update

GlobeNewswire April 8, 2020

Neuronetics Recognized as 2020 Top Neurology Device Provider

GlobeNewswire March 30, 2020

Neuronetics® Hits Major Milestones with More Than 2.5 Million Treatments and 1,000 Installations of Its NeuroStar® Advanced Therapy System

GlobeNewswire March 16, 2020

FDA Grants NeuroStar® Advanced Therapy System Breakthrough Device Designation to Treat Bipolar Depression

GlobeNewswire March 6, 2020

Neuronetics, Inc. announces Chris Thatcher will step down as President and CEO

GlobeNewswire March 5, 2020

Neuronetics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results

GlobeNewswire March 3, 2020

Neuronetics to Report Fourth Quarter and Fiscal Year 2019 Financial and Operating Results and Host Conference Call

GlobeNewswire February 18, 2020

Anika Therapeutics Names Board Member Dr. Cheryl Blanchard as Interim CEO

GlobeNewswire February 12, 2020

Neuronetics Appoints Andrew Macan As Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary

GlobeNewswire January 21, 2020